Clinical Trial Update: A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids [Phase 3]

View source ↗

Summary

Phase III double-blind trial of idebenone in Duchenne Muscular Dystrophy patients on glucocorticoids; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Idebenone (idebenone)

Snippet

Sponsor: Santhera Pharmaceuticals | Conditions: Duchenne Muscular Dystrophy (DMD) | Phase 3 | Status: TERMINATED